Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study.

Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan MP, Koren G.

BJOG. 2004 Sep;111(9):940-3.

2.

Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy.

Portnoi G, Chng LA, Karimi-Tabesh L, Koren G, Tan MP, Einarson A.

Am J Obstet Gynecol. 2003 Nov;189(5):1374-7. Erratum in: Am J Obstet Gynecol. 2004 Apr;190(4):1140. Karimi-Tabesh, Linda [corrected to Karimi-Tabesh, Lida].

PMID:
14634571
3.

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A.

J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546.

PMID:
15816786
4.

Pregnancy outcome following use of large doses of vitamin B6 in the first trimester.

Shrim A, Boskovic R, Maltepe C, Navios Y, Garcia-Bournissen F, Koren G.

J Obstet Gynaecol. 2006 Nov;26(8):749-51.

PMID:
17130022
5.

The use of CAM by women suffering from nausea and vomiting during pregnancy.

Hollyer T, Boon H, Georgousis A, Smith M, Einarson A.

BMC Complement Altern Med. 2002 May 17;2:5.

6.

Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study.

Berkovitch M, Mazzota P, Greenberg R, Elbirt D, Addis A, Schuler-Faccini L, Merlob P, Arnon J, Stahl B, Magee L, Moretti M, Ornoy A.

Am J Perinatol. 2002 Aug;19(6):311-6.

PMID:
12357422
7.

Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically.

Baggley A, Navioz Y, Maltepe C, Koren G, Einarson A.

J Midwifery Womens Health. 2004 Jul-Aug;49(4):350-4.

PMID:
15236716
8.

The perception of teratogenic risk by women with nausea and vomiting of pregnancy.

Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G.

Reprod Toxicol. 1999 Jul-Aug;13(4):313-9. Erratum in: Reprod Toxicol 1999 Nov-Dec;13(6):573.

PMID:
10453916
9.

Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing.

Boskovic R, Einarson A, Maltepe C, Wolpin J, Koren G.

J Obstet Gynaecol Can. 2003 Oct;25(10):830-3.

PMID:
14532951
10.

The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy.

Atanackovic G, Navioz Y, Moretti ME, Koren G.

J Clin Pharmacol. 2001 Aug;41(8):842-5.

PMID:
11504271
11.

Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.

Aouad MT, Siddik-Sayyid SM, Taha SK, Azar MS, Nasr VG, Hakki MA, Zoorob DG, Baraka AS.

Eur J Anaesthesiol. 2007 Feb;24(2):171-8. Epub 2006 Aug 29.

PMID:
16938159
12.

Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.

Lindley C, Goodin S, McCune J, Kane M, Amamoo MA, Shord S, Pham T, Yowell S, Laliberte K, Schell M, Bernard S, Socinski MA.

Am J Clin Oncol. 2005 Jun;28(3):270-6.

PMID:
15923800
13.

Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.

Warden CR, Moreno R, Daya M.

Prehosp Emerg Care. 2008 Jan-Mar;12(1):87-91. doi: 10.1080/10903120701707963.

PMID:
18189184
14.

Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.

Walsh T, Morris AK, Holle LM, Callander N, Bradshaw P, Valley AW, Clark G, Freytes CO.

Bone Marrow Transplant. 2004 Dec;34(11):963-8.

PMID:
15489869
15.

Motherisk update. Is ondansetron safe for use during pregnancy?

Koren G.

Can Fam Physician. 2012 Oct;58(10):1092-3.

16.

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.

Meiri E, Jhangiani H, Vredenburgh JJ, Barbato LM, Carter FJ, Yang HM, Baranowski V.

Curr Med Res Opin. 2007 Mar;23(3):533-43.

PMID:
17355735
17.

Is lack of morning sickness teratogenic? A prospective controlled study.

Boskovic R, Rudic N, Danieliewska-Nikiel B, Navioz Y, Koren G.

Birth Defects Res A Clin Mol Teratol. 2004 Aug;70(8):528-30.

PMID:
15329830
18.

Nausea and vomiting in pregnancy: what advice do midwives give?

Wills G, Forster D.

Midwifery. 2008 Dec;24(4):390-8. Epub 2007 Sep 11.

PMID:
17850938
19.

Ondansetron in pregnancy and risk of adverse fetal outcomes.

Pasternak B, Svanström H, Hviid A.

N Engl J Med. 2013 Feb 28;368(9):814-23. doi: 10.1056/NEJMoa1211035. Erratum in: N Engl J Med. 2013 May 30;368(22):2146.

20.

Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP).

Magee LA, Mazzotta P, Koren G.

Am J Obstet Gynecol. 2002 May;186(5 Suppl Understanding):S256-61. Review.

PMID:
12011897

Supplemental Content

Support Center